Entry Point Capital, LLC Bioventus Inc. Transaction History

Entry Point Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$6.2 - $9.51 $98,102 - $150,476	-15,823 Reduced 55.77%	12,548 $83,000
Q1 2025 May 14, 2025	BUY	$8.76 - $11.05 $17,940 - $22,630	2,048 Added 7.78%	28,371 $259,000
Q4 2024 Feb 11, 2025	SELL	$10.5 - $13.71 $136,279 - $177,942	-12,979 Reduced 33.02%	26,323 $276,000
Q3 2024 Nov 13, 2024	BUY	$5.73 - $11.95 $225,200 - $469,658	39,302 New	39,302 $469,000
Q4 2023 Feb 14, 2024	BUY	$2.89 - $5.34 $26,978 - $49,848	9,335 New	9,335 $49.2 Million

144

50.1M

42.5K

100K

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $453M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

Get notified when there are updates to the investment portfolio of Entry Point Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Entry Point Capital, LLC with notifications on news.